Blackhill Capital Inc
13F filer · CIK 0000872162Reported Aug 13, 2026
Net seller this quarter
13F portfolio value$2.41BU.S. long equity reported on 13F
Positions470 new · 2 closed
Net flow last quarter-$3.9MBuys minus sells
Top 10 positions weight94.9%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 13, 202647 positions | |||||
| $1.79B | 74.32% | 6.53% | 0.0% | Q2 2013 | |
| $174M | 7.22% | 0.02% | -0.4% | Q2 2013 | |
| $71.8M | 2.98% | 0.00% | Not reported | Q2 2015 | |
| $66.2M | 2.75% | 0.01% | Not reported | Q2 2013 | |
| $63.4M | 2.63% | 0.01% | Not reported | Q2 2013 | |
| $30.6M | 1.27% | 0.05% | +33.3% | Q2 2013 | |
| $28M | 1.16% | 0.00% | Not reported | Q4 2023 | |
| $24.6M | 1.02% | 0.00% | Not reported | Q3 2017 | |
| $21.7M | 0.90% | 0.01% | Not reported | Q2 2013 | |
| $16.3M | 0.68% | 0.00% | Not reported | Q2 2013 | |
| $16.1M | 0.67% | 0.01% | -33.7% | Q2 2013 | |
| $15.9M | 0.66% | 0.01% | Not reported | Q2 2015 | |
| $10.6M | 0.44% | Not reported | Not reported | Q2 2015 | |
| $10.3M | 0.43% | 0.00% | Not reported | Q2 2013 | |
| $9.77M | 0.41% | 0.01% | Not reported | Q2 2015 | |
| $8.72M | 0.36% | 0.00% | Not reported | Q4 2016 | |
| $6.58M | 0.27% | 0.00% | Not reported | Q2 2013 | |
| $6.24M | 0.26% | Not reported | Not reported | Q3 2015 | |
| $5.71M | 0.24% | 0.00% | Not reported | Q3 2015 | |
| $4.91M | 0.20% | 0.02% | -28.8% | Q2 2013 | |
| $4.49M | 0.19% | Not reported | Not reported | Q2 2013 | |
| $3.96M | 0.16% | 0.01% | Not reported | Q2 2013 | |
| $3.62M | 0.15% | 0.02% | Not reported | Q2 2013 | |
| $3.18M | 0.13% | 0.01% | Not reported | Q2 2013 | |
| $1.91M | 0.08% | 0.00% | Not reported | Q2 2013 | |
| $1.14M | 0.05% | 0.00% | Not reported | Q2 2013 | |
| $998K | 0.04% | 0.01% | Not reported | Q1 2020 | |
| $892K | 0.04% | 0.03% | Not reported | Q2 2013 | |
| $811K | 0.03% | 0.00% | Not reported | Q2 2013 | |
| $789K | 0.03% | 0.00% | Not reported | Q2 2013 | |
| $760K | 0.03% | 0.00% | Not reported | Q2 2013 | |
| $666K | 0.03% | 0.00% | Not reported | Q1 2019 | |
| $663K | 0.03% | 0.00% | Not reported | Q4 2018 | |
| $628K | 0.03% | 0.00% | Not reported | Q2 2013 | |
| $465K | 0.02% | 0.00% | Not reported | Q1 2019 | |
| $458K | 0.02% | 0.00% | Not reported | Q2 2013 | |
| $374K | 0.02% | 0.04% | Not reported | Q2 2013 | |
| $370K | 0.02% | 0.01% | Not reported | Q2 2013 | |
| $357K | 0.01% | Not reported | Not reported | Q2 2013 | |
| $247K | 0.01% | Not reported | Not reported | Q2 2013 | |
| $114K | 0.00% | 0.00% | Not reported | Q3 2020 | |
| $105K | 0.00% | 0.00% | Not reported | Q1 2014 | |
| $84.1K | 0.00% | 0.00% | Not reported | Q1 2024 | |
| $62.9K | 0.00% | 0.00% | Not reported | Q2 2013 | |
| AMAVNSAvanos Medical, Inc. | $59.1K | 0.00% | 0.01% | Not reported | Q4 2018 |
| $52.1K | 0.00% | Not reported | +3.0% | Q2 2013 | |
| $28K | 0.00% | 0.00% | Not reported | Q2 2013 | |
| Q1 2026Reported May 14, 202649 positions | |||||
| $1.4B | 72.12% | 6.46% | -0.1% | Q2 2013 | |
| $134M | 6.90% | 0.02% | -0.2% | Q2 2013 | |
| $63M | 3.24% | 0.00% | -0.5% | Q2 2015 | |
| $57.2M | 2.95% | 0.01% | +6.5% | Q2 2013 | |
| $42.2M | 2.17% | 0.01% | -0.8% | Q2 2013 | |
| $27.6M | 1.42% | 0.02% | Not reported | Q2 2013 | |
| $24.4M | 1.26% | 0.00% | Not reported | Q3 2017 | |
| $24.4M | 1.26% | 0.00% | Not reported | Q4 2023 | |
| $23.2M | 1.19% | 0.03% | +3.5% | Q2 2013 | |
| $20.3M | 1.05% | 0.01% | Not reported | Q2 2013 | |
| $16.7M | 0.86% | 0.01% | -1.9% | Q2 2015 | |
| $15.7M | 0.81% | 0.00% | Not reported | Q2 2013 | |
| $11.3M | 0.58% | 0.02% | Not reported | Q2 2013 | |
| $10.2M | 0.52% | Not reported | Not reported | Q2 2015 | |
| $9.99M | 0.51% | 0.00% | Not reported | Q2 2013 | |
| $9.78M | 0.50% | 0.01% | Not reported | Q2 2015 | |
| $7.62M | 0.39% | 0.00% | Not reported | Q4 2016 | |
| $6.48M | 0.33% | 0.00% | Not reported | Q2 2013 | |
| $5.07M | 0.26% | Not reported | Not reported | Q3 2015 | |
| $4.6M | 0.24% | 0.00% | Not reported | Q3 2015 | |
| $4.31M | 0.22% | Not reported | Not reported | Q2 2013 | |
| $4.08M | 0.21% | 0.01% | Not reported | Q2 2013 | |
| $3.8M | 0.20% | 0.02% | Not reported | Q2 2013 | |
| $2.8M | 0.14% | 0.01% | Not reported | Q2 2013 | |
| $2.39M | 0.12% | 0.00% | Not reported | Q2 2013 | |
| $1.32M | 0.07% | 0.00% | Not reported | Q2 2013 | |
| $1.05M | 0.05% | 0.01% | Not reported | Q1 2020 | |
| $932K | 0.05% | 0.00% | Not reported | Q2 2013 | |
| $817K | 0.04% | 0.03% | Not reported | Q2 2013 | |
| $817K | 0.04% | 0.00% | Not reported | Q2 2013 | |
| $763K | 0.04% | 0.00% | Not reported | Q4 2018 | |
| $694K | 0.04% | 0.00% | Not reported | Q2 2013 | |
| $641K | 0.03% | 0.00% | Not reported | Q2 2013 | |
| $508K | 0.03% | 0.01% | +170.8% | Q2 2013 | |
| $463K | 0.02% | 0.00% | Not reported | Q1 2019 | |
| $452K | 0.02% | 0.00% | Not reported | Q1 2019 | |
| $426K | 0.02% | 0.00% | Not reported | Q2 2013 | |
| $347K | 0.02% | 0.04% | Not reported | Q2 2013 | |
| $345K | 0.02% | 0.01% | Not reported | Q2 2013 | |
| $311K | 0.02% | Not reported | Not reported | Q2 2013 | |
| $216K | 0.01% | Not reported | Not reported | Q2 2013 | |
| $125K | 0.01% | 0.00% | Not reported | Q1 2014 | |
| $74.4K | 0.00% | 0.00% | Not reported | Q1 2024 | |
| $71.2K | 0.00% | 0.00% | Not reported | Q3 2020 | |
| $62.5K | 0.00% | 0.00% | Not reported | Q3 2025 | |
| $57.4K | 0.00% | 0.00% | Not reported | Q2 2013 | |
| $54.6K | 0.00% | Not reported | -2.9% | Q2 2013 | |
| AMAVNSAvanos Medical, Inc. | $33.3K | 0.00% | 0.01% | Not reported | Q4 2018 |
| $28.6K | 0.00% | 0.00% | Not reported | Q2 2013 | |
| Q4 2025Reported Feb 13, 202650 positions | |||||
| $1.37B | 70.65% | 6.44% | -0.2% | Q2 2013 | |
| $157M | 8.07% | 0.02% | -0.1% | Q2 2013 | |
| $67.8M | 3.49% | 0.00% | -0.1% | Q2 2015 | |
| $56.5M | 2.91% | 0.01% | +0.1% | Q2 2013 | |
| $34.4M | 1.77% | 0.01% | Not reported | Q2 2013 | |
| $33.6M | 1.73% | 0.02% | +0.1% | Q2 2013 | |
| $31.9M | 1.64% | 0.00% | Not reported | Q3 2017 | |
| $26.1M | 1.34% | 0.00% | +0.3% | Q4 2023 | |
| $19.1M | 0.98% | 0.03% | +65.7% | Q2 2013 | |
| $17.8M | 0.91% | 0.01% | Not reported | Q2 2013 | |
| $15.1M | 0.78% | 0.01% | Not reported | Q2 2015 | |
| $13.3M | 0.68% | 0.00% | Not reported | Q2 2013 | |
| $12.1M | 0.62% | 0.02% | -27.0% | Q2 2013 | |
| $11.5M | 0.59% | 0.01% | Not reported | Q2 2015 | |
| $11.4M | 0.59% | 0.00% | Not reported | Q2 2013 | |
| $10.7M | 0.55% | Not reported | Not reported | Q2 2015 | |
| $8.44M | 0.43% | 0.00% | Not reported | Q4 2016 | |
| $6.43M | 0.33% | 0.00% | Not reported | Q2 2013 | |
| $5.54M | 0.29% | Not reported | Not reported | Q3 2015 | |
| $5M | 0.26% | 0.00% | Not reported | Q3 2015 | |
| $4.53M | 0.23% | Not reported | Not reported | Q2 2013 | |
| $3.78M | 0.19% | 0.02% | -21.9% | Q2 2013 | |
| $3.45M | 0.18% | 0.01% | Not reported | Q2 2013 | |
| $2.93M | 0.15% | 0.01% | Not reported | Q2 2013 | |
| $1.76M | 0.09% | 0.00% | Not reported | Q2 2013 | |
| $1.17M | 0.06% | 0.00% | Not reported | Q2 2013 | |
| $999K | 0.05% | 0.01% | Not reported | Q1 2020 | |
| $917K | 0.05% | 0.00% | Not reported | Q2 2013 | |
| $819K | 0.04% | 0.00% | Not reported | Q4 2018 | |
| $783K | 0.04% | 0.00% | Not reported | Q2 2013 | |
| $783K | 0.04% | 0.03% | Not reported | Q2 2013 | |
| $674K | 0.03% | 0.00% | Not reported | Q2 2013 | |
| $622K | 0.03% | 0.00% | Not reported | Q2 2013 | |
| $428K | 0.02% | 0.00% | -4.6% | Q1 2019 | |
| $408K | 0.02% | 0.00% | Not reported | Q1 2019 | |
| $395K | 0.02% | 0.00% | Not reported | Q2 2013 | |
| PPCHPotlatch Corp | $340K | 0.02% | 0.01% | Not reported | Q2 2013 |
| $336K | 0.02% | 0.04% | Not reported | Q2 2013 | |
| $329K | 0.02% | 0.01% | Not reported | Q2 2013 | |
| $326K | 0.02% | Not reported | Not reported | Q2 2013 | |
| $212K | 0.01% | Not reported | Not reported | Q2 2013 | |
| $197K | 0.01% | 0.01% | +4.9% | Q2 2013 | |
| $109K | 0.01% | 0.00% | Not reported | Q1 2014 | |
| $97.2K | 0.01% | 0.00% | -48.5% | Q3 2020 | |
| $89.9K | 0.00% | 0.00% | Not reported | Q1 2024 | |
| $60.9K | 0.00% | 0.00% | +30.0% | Q3 2025 | |
| $57.7K | 0.00% | 0.00% | Not reported | Q2 2013 | |
| $46.9K | 0.00% | Not reported | Not reported | Q2 2013 | |
| AMAVNSAvanos Medical, Inc. | $26.7K | 0.00% | 0.01% | -23.3% | Q4 2018 |
| $25.1K | 0.00% | 0.00% | Not reported | Q2 2013 | |
| Q3 2025Reported Nov 13, 202551 positions | |||||
| $1.51B | 74.52% | 6.32% | -0.3% | Q2 2013 | |
| $111M | 5.52% | 0.02% | -0.2% | Q2 2013 | |
| $63.6M | 3.15% | 0.00% | -2.4% | Q2 2015 | |
| $57.1M | 2.83% | 0.01% | -2.4% | Q2 2013 | |
| $35.9M | 1.78% | 0.02% | -3.6% | Q2 2013 | |
| $34.2M | 1.69% | 0.00% | Not reported | Q3 2017 | |
| $28.6M | 1.42% | 0.01% | Not reported | Q2 2013 | |
| $26M | 1.29% | 0.00% | Not reported | Q4 2023 | |
| $19.2M | 0.95% | 0.03% | +3.8% | Q2 2013 | |
| $14.2M | 0.70% | 0.01% | -4.4% | Q2 2013 | |
| $12.7M | 0.63% | 0.01% | -0.3% | Q2 2015 | |
| $12M | 0.59% | 0.02% | Not reported | Q2 2013 | |
| $11.9M | 0.59% | 0.00% | -3.0% | Q2 2013 | |
| $11.6M | 0.58% | 0.01% | Not reported | Q2 2015 | |
| $11.4M | 0.56% | 0.00% | Not reported | Q2 2013 | |
| $10.7M | 0.53% | Not reported | 0.0% | Q2 2015 | |
| $8.03M | 0.40% | 0.00% | Not reported | Q4 2016 | |
| $6.89M | 0.34% | 0.00% | Not reported | Q2 2013 | |
| $5.3M | 0.26% | 0.03% | Not reported | Q2 2013 | |
| $4.53M | 0.22% | Not reported | Not reported | Q2 2013 | |
| $4.3M | 0.21% | Not reported | Not reported | Q3 2015 | |
| $3.88M | 0.19% | 0.00% | Not reported | Q3 2015 | |
| $3.61M | 0.18% | 0.01% | Not reported | Q2 2013 | |
| $3.37M | 0.17% | 0.01% | -0.9% | Q2 2013 | |
| $1.79M | 0.09% | 0.00% | Not reported | Q2 2013 | |
| $1.4M | 0.07% | 0.00% | -3.4% | Q3 2023 | |
| $1.2M | 0.06% | 0.00% | -1.0% | Q2 2013 | |
| $1.04M | 0.05% | 0.01% | Not reported | Q1 2020 | |
| $931K | 0.05% | 0.00% | Not reported | Q4 2018 | |
| $912K | 0.05% | 0.00% | Not reported | Q2 2013 | |
| $835K | 0.04% | 0.00% | Not reported | Q2 2013 | |
| $792K | 0.04% | 0.03% | Not reported | Q2 2013 | |
| $681K | 0.03% | 0.00% | Not reported | Q2 2013 | |
| $650K | 0.03% | 0.00% | Not reported | Q2 2013 | |
| $517K | 0.03% | 0.00% | Not reported | Q1 2019 | |
| $400K | 0.02% | 0.00% | Not reported | Q2 2013 | |
| $399K | 0.02% | 0.00% | Not reported | Q1 2019 | |
| $361K | 0.02% | 0.04% | Not reported | Q2 2013 | |
| $349K | 0.02% | 0.01% | Not reported | Q2 2013 | |
| PPCHPotlatch Corp | $348K | 0.02% | 0.01% | Not reported | Q2 2013 |
| $318K | 0.02% | Not reported | Not reported | Q2 2013 | |
| $253K | 0.01% | 0.01% | Not reported | Q3 2020 | |
| $230K | 0.01% | 0.01% | Not reported | Q2 2013 | |
| $209K | 0.01% | Not reported | Not reported | Q2 2013 | |
| $112K | 0.01% | 0.00% | Not reported | Q1 2014 | |
| $88.9K | 0.00% | 0.00% | Not reported | Q1 2024 | |
| $60.1K | 0.00% | 0.00% | Not reported | Q2 2013 | |
| $59.9K | 0.00% | 0.00% | New | Q3 2025 | |
| $53.6K | 0.00% | Not reported | Not reported | Q2 2013 | |
| AMAVNSAvanos Medical, Inc. | $35.8K | 0.00% | 0.01% | Not reported | Q4 2018 |
Premium opens every quarter this fund has filed